HomeAI · summaries
Storia in 4 fonti
Cancer drug prices raised 50% as NPPA acts on shortage concerns
India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follows pleas from manufacturers citing soaring platinum costs. Anti-tetanus immunoglobulin drug prices also see an increase. The National Pharmaceutical Pricing Authority invoked special powers to ensure these life-saving medicines remain accessible to the public.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Indian cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces…
- ·
thehindubusinessline.com
Cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India face a severe shortage of platinum-based drugs due to rising costs and supply disruptions.
